An analysis of the Novavax COVID-19 vaccine using clinical and real-world data found that the benefits outweighed the risk of myocarditis or pericarditis, a team…
Comments closedTag: Novavax
Topic: vaccinesView all posts for the topic: vaccines
Older, immunocompromised people may get COVID-19 vaccine dose in spring, NACI says
Canada’s National Advisory Committee on Immunization says some groups of people vulnerable to severe illness from COVID-19 should be eligible for another dose of vaccine in the spring.
The recommendation issued Friday says people aged 65 and older, residents of long-term care homes and seniors living in other congregate settings may get another shot of the vaccine targeted to the XBB.1.5 variant.
It also says children and adults aged six months and older who are moderately to severely immunocompromised due to an underlying condition may also get the booster.
Comments closedTopic: AlbertaView all posts for the topic: Alberta
Albertans can now book appointments for the updated Novavax vaccine
A limited supply of the updated Novavax vaccine is rolling out in Alberta this week with appointment booking starting Wednesday and shots going into arms as of Friday.
Alberta Health said it has approximately 5,000 doses of the Novavax XBB.1.5 vaccine in stock.
The latest version of the protein-based vaccine was approved by Health Canada in early December.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Just 15% of Canadians got updated COVID vaccines this fall, new figures show
Canadians raced to get vaccinated against COVID-19 in the first years of the pandemic, but data suggests there’s far less of a rush to get the latest shots available this fall.
Federal figures show only 15 per cent of the population aged five and up had received an updated vaccine by Dec. 3. And while older age groups had higher uptake rates, more than half of higher-risk older adults still hadn’t gotten a dose by early December, either.
Comments closed
Topic: NovavaxView all posts for the topic: Novavax
Health Canada approves updated Novavax vaccine to protect against COVID-19
Health Canada has authorized an adapted vaccine from Novavax to prevent COVID-19 in people age 12 and older.
The vaccine uses a traditional approach to defend the body against COVID.
It contains a version of the viral spike protein and is also authorized as a booster for those 18 and older, according to Health Canada’s webpage.
Comments closedTopic: NovavaxView all posts for the topic: Novavax
Does Novavax’s Covid vaccine cause fewer side effects?
Erin Kissane, a co-founder of the COVID Tracking Project, rolled up her sleeve for the Novavax Covid-19 vaccine in mid-October soon after it was finally recommended in the United States. Like many people with autoimmune diseases, she wants to protect herself from a potentially devastating Covid infection.
Kissane’s autoimmune arthritis seems to make her susceptible to unusual vaccine side effects. After getting an mRNA booster last year, her joints ached so painfully that her doctor prescribed steroids to dampen the inflammation. She still considers the mRNA vaccines “miraculous,” knowing Covid could be far worse than temporary aches.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far
As the updated COVID vaccines roll out around the country, one more competitor has joined the mix. In early October the U.S. Food and Drug Administration authorized a new booster shot made by the company Novavax. Like the mRNA-based Pfizer and Moderna shots, it targets a SARS-CoV-2 variant, XBB.1.5, which is a descendant of Omicron.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
EU delays approval of Novavax’s revised COVID vaccine
European Union (EU) regulators have delayed a decision to give approval for Novavax’s (NVAX.O) variant-tailored COVID-19 vaccine, the Financial Times said on Sunday.
The European Medicines Agency (EMA), which was due to approve the updated vaccine last Friday has requested more information from the company, the FT report added.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Novavax touts non-mRNA COVID-19 vaccine, hopeful to meet domestic production deadline
The last remaining manufacturer to offer an alternative to mRNA COVID-19 vaccines in Canada is hopeful it will meet the government’s 2024 deadline to make the shots domestically.
Comments closedTopic: NovavaxView all posts for the topic: Novavax
Novavax espère toujours fabriquer un vaccin contre la COVID-19 au Canada
The last manufacturer to offer an alternative to COVID-19 mRNA vaccines in Canada hopes to meet the government’s 2024 deadline for domestic dose production.
Novavax, based in Maryland, USA, held a press conference on Wednesday to tout the safety and efficacy of its new vaccine, which targets newer strains of COVID-19.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
FDA authorizes Novavax’s updated COVID vaccine for fall 2023
The Food and Drug Administration announced Tuesday it had authorized Novavax’s updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.
Comments closedTopic: vaccinesView all posts for the topic: vaccines
Updated Covid-19 vaccines are coming mid-September, officials say
Covid-19 vaccines that have been tweaked to teach the body how to fend off the current crop of circulating variants are now expected to land in drugstores and clinics in mid-September, CDC and FDA officials said.
Comments closed